These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, Higuchi H, Akiba Y, Hokari R, Hirokawa M, Serizawa H, Ishii H. Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061 [Abstract] [Full Text] [Related]
3. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ, Moncada S. Lancet; 1993 Aug 07; 342(8867):338-40. PubMed ID: 7687730 [Abstract] [Full Text] [Related]
5. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Guihot G, Guimbaud R, Bertrand V, Narcy-Lambare B, Couturier D, Duée PH, Chaussade S, Blachier F. Amino Acids; 2000 Aug 07; 18(3):229-37. PubMed ID: 10901620 [Abstract] [Full Text] [Related]
6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T, May B, Pfisterer O, Müller KM, Brasch F. Hepatogastroenterology; 2002 Aug 07; 49(43):116-23. PubMed ID: 11941933 [Abstract] [Full Text] [Related]
7. Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease. Boughton-Smith NK. J R Soc Med; 1994 Jun 07; 87(6):312-4. PubMed ID: 7519268 [No Abstract] [Full Text] [Related]
8. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Daig R, Andus T, Aschenbrenner E, Falk W, Schölmerich J, Gross V. Gut; 1996 Feb 07; 38(2):216-22. PubMed ID: 8801200 [Abstract] [Full Text] [Related]
9. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H. Gut; 1998 Feb 07; 42(2):180-7. PubMed ID: 9536941 [Abstract] [Full Text] [Related]
10. Mucosal metabolism in ulcerative colitis and Crohn's disease. Duffy MM, Regan MC, Ravichandran P, O'Keane C, Harrington MG, Fitzpatrick JM, O'Connell PR. Dis Colon Rectum; 1998 Nov 07; 41(11):1399-405. PubMed ID: 9823806 [Abstract] [Full Text] [Related]
11. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis. Yokoyama K, Mitomi H, Kobayashi K, Katsumata T, Saigenji K, Okayasu I. Hepatogastroenterology; 2001 Nov 07; 48(38):401-7. PubMed ID: 11379318 [Abstract] [Full Text] [Related]
12. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode. Iwashita E. J Gastroenterol Hepatol; 1998 Apr 07; 13(4):391-5. PubMed ID: 9641303 [Abstract] [Full Text] [Related]
13. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Perner A, Andresen L, Normark M, Fischer-Hansen B, Sørensen S, Eugen-Olsen J, Rask-Madsen J. Gut; 2001 Sep 07; 49(3):387-94. PubMed ID: 11511561 [Abstract] [Full Text] [Related]
14. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease. Szewczuk MR, Depew WT. Clin Invest Med; 1992 Feb 07; 15(1):49-59. PubMed ID: 1374000 [Abstract] [Full Text] [Related]
15. Serum nitrate levels in ulcerative colitis and Crohn's disease. Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SG, Peña AS. Scand J Gastroenterol; 1995 Aug 07; 30(8):784-8. PubMed ID: 7481547 [Abstract] [Full Text] [Related]
16. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. Leonard N, Bishop AE, Polak JM, Talbot IC. J Clin Pathol; 1998 Oct 07; 51(10):750-3. PubMed ID: 10023337 [Abstract] [Full Text] [Related]
17. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Griga T, Voigt E, Gretzer B, Brasch F, May B. Hepatogastroenterology; 1999 Oct 07; 46(26):920-3. PubMed ID: 10370639 [Abstract] [Full Text] [Related]
18. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF. Eur J Gastroenterol Hepatol; 2002 Jul 07; 14(7):745-52. PubMed ID: 12169983 [Abstract] [Full Text] [Related]
19. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Gut; 1994 Nov 07; 35(11):1593-8. PubMed ID: 7828979 [Abstract] [Full Text] [Related]
20. Nitric oxide and inflammatory bowel diseases. Guslandi M. Eur J Clin Invest; 1998 Nov 07; 28(11):904-7. PubMed ID: 9824433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]